To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.
Retrieved from the GovBot source 9/24/2026, 3:56:22 AM (UTC). Viewing this record does not change stored data.
At a glance
- Bill number
- HR 1843
- Status
- Not provided
- Latest recorded action
- Referred to the House Committee on Energy and Commerce.
Summary
Not provided in this source record.
Recorded activity
Newest date first. Actions with the same timestamp retain source order.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Retrieval & source record
- Search index built (UTC)
- 2026-09-07T10:23:11.520Z
- Dataset
- govbot-data/usa-legislation
- Retrieved (UTC)
- 2026-09-24T03:56:22.709Z
- Live source branch
- main (mutable; checksum identifies the retrieved record)
- Search index revision
b5b4a6d28d2dd595bb5724470458ffceaf19bcb7- Original record
- View GovBot metadata JSON (opens in a new tab)
- Record SHA-256
c9b45d9f5b1d38ac4894d05af474d658408c86d4dba5b2c805977c8c4646e748